Browse Pet Safety Reports
18,010 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,010 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,010 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Feb 10, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Feb 10, 2025 | Horse | Arab | Leucoreduced Allogeneic Pooled Freeze... | Hepatitis | Euthanized |
| Feb 10, 2025 | Horse | Crossbred Equine/horse | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Ongoing |
| Feb 10, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS; Cough; Anorexia; Depression; Other abnormal test resu... | Outcome Unknown |
| Feb 9, 2025 | Horse | Horse (unknown) | Polysulfated Glycosaminoglycan | Musculoskeletal pain; Injection site abscess; Defect Unknown/Not Specified | Recovered/Normal |
| Feb 9, 2025 | Horse | Horse (unknown) | Polysulfated Glycosaminoglycan | Musculoskeletal pain; Injection site abscess; Scar | Recovered/Normal |
| Feb 6, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Injection site tenderness; Muscle stiffness | Recovered/Normal |
| Feb 6, 2025 | Horse | Standardbred (unspecified) | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Outcome Unknown |
| Feb 5, 2025 | Horse | Thoroughbred | Ivermectin; Praziquantel | Oral ulceration; Oral swelling; Colic | Recovered/Normal |
| Feb 5, 2025 | Horse | Welsh Pony | Pergolide Mesylate | Fear/fearful | Outcome Unknown |
| Feb 5, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Feb 4, 2025 | Horse | Horse (other) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 4, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 3, 2025 | Horse | Quarter Horse | Butorphanol Tartrate | Diarrhoea | Recovered/Normal |
| Feb 3, 2025 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Feb 3, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Feb 3, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Feb 3, 2025 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site pain; Injection site warmth; Fever | Ongoing |
| Feb 3, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Feb 3, 2025 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 30, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jan 30, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 29, 2025 | Horse | Horse (unknown) | Fenbendazol Oral Paste | Swollen eye; Ocular discharge | Ongoing |
| Jan 28, 2025 | Horse | Arab | Ceftiofur Crystalline Free Acid | Colic; Tachycardia; Recumbency; Elevated liver enzymes NOS; Elevated blood ur... | Euthanized |
| Jan 27, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 26, 2025 | Horse | Warmblood (unspecified) | Pergolide Mesylate | Behavioural disorder NOS | Outcome Unknown |
| Jan 25, 2025 | Horse | Quarter Horse | Pergolide Mesylate | Stiffness NOS; Recumbency | Outcome Unknown |
| Jan 23, 2025 | Horse | Crossbred Equine/horse, Con... | Flunixin Meglumine Oral Paste | Increased sweating; Decreased body temperature; Shaking; Lying down; Fever; D... | Ongoing |
| Jan 22, 2025 | Horse | Quarter Horse | Pergolide Mesylate | Laminitis; High adrenocorticotropic (ACTH) hormone; Elevated insulin | Outcome Unknown |
| Jan 21, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 21, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 20, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 20, 2025 | Horse | Paint | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jan 18, 2025 | Horse | Morgan | Pentosan Polysulfate Sodium | Rubbing; Flehmen response; Excessive sweating; Agitation; Pruritus; Hives (se... | Recovered/Normal |
| Jan 18, 2025 | Horse | Oldenburg | Clodronate Disodium | Not eating; Blood in urine; Elevated creatinine; Thrombocytopenia; Lymphopeni... | Outcome Unknown |
| Jan 17, 2025 | Horse | Horse (unknown) | Ceftiofur Crystalline Free Acid | Abortion; Medication error NOS | Outcome Unknown |
| Jan 17, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jan 16, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jan 16, 2025 | Horse | Quarter Horse | Praziquantel;Moxidectin | Ataxia; Neurological signs NOS | Ongoing |
| Jan 15, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 15, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jan 15, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 15, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 15, 2025 | Horse | Horse (unknown) | Pergolide Mesylate | Decreased appetite | Outcome Unknown |
| Jan 15, 2025 | Horse | Warmblood - Belgian | Sulfadiazine Sodium And Pyrimethamine | CULTURE/TITER DATA ABNORMAL; Gait abnormality; Behavioural disorder NOS; Chew... | Outcome Unknown |
| Jan 15, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jan 14, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jan 13, 2025 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jan 13, 2025 | Horse | Welsh Cob, Arab | Praziquantel;Moxidectin | Diarrhoea | Recovered/Normal |
| Jan 12, 2025 | Horse | Warmblood (unspecified) | Ponazuril | Death by euthanasia; Hind limb paralysis | Euthanized |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.